Company CollPlant Biotechnologies Ltd.

Equities

CLGN

IL0004960188

Biotechnology & Medical Research

Analysts' Consensus

Business Summary

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Ratings for CollPlant Biotechnologies Ltd.

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Bio Medical Devices

Market Closed - Nasdaq Other stock markets 04:30:00 2024-04-29 pm EDT			5-day change	1st Jan Change
5.97 ^USD	+1.36%		+10.56%	-6.57%

Apr. 04	CollPlant Biotechnologies Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Jan. 02	CollPlant Biotechnologies Begins Preclinical Trial with Commercial-Size, Regenerative Breast Implants	CI

CollPlant Biotechnologies Ltd, formerly known as Collplant Holdings Ltd, is a company dealing in aesthetic medicine and regenerative medicine based in Israel. The company provides products and technologies for broadly understood regenerative medicine, including tissue regeneration and organ production. The technology is based on plants and is based on the production of collagen type I (rhCollagen).

Number of employees: 75

Managers	Title	Age	Since
Yehiel Tal CEO	Chief Executive Officer	71	09-12-31
Oded Shoseyov FOU	Founder	67	04-05-31
Eran Rotem DFI	Director of Finance/CFO	56	11-12-31
Oren Fahimipoor COO	Chief Operating Officer	42	-
Elana Gazal CTO	Chief Tech/Sci/R&D Officer	49	21-12-31
Hadas Dreiher-Horowitz HRO	Human Resources Officer	47	21-02-28
Philippe Bensimon LAW	General Counsel	58	11-01-31
Dana Gottesman Erlich AUD	Comptroller/Controller/Auditor	48	13-11-26

Members of the board	Title	Age	Since
Avri Havron BRD	Director/Board Member	75	16-04-30
Hugh Evans BRD	Director/Board Member	57	21-03-28
Elan Penn BRD	Director/Board Member	72	17-12-31
Oded Shoseyov FOU	Founder	67	04-05-31
Yehiel Tal CEO	Chief Executive Officer	71	09-12-31
Roger Pomerantz CHM	Chairman	67	20-02-09
Joseph Zarzewsky BRD	Director/Board Member	63	19-07-31
Alisa Lask BRD	Director/Board Member	53	21-08-18

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	11,454,512	7,819,939 ( 68.27 %)	0	68.27 %

Name	Equities	%	Valuation
Ami Sagi 16.97 %	1,943,184	16.97 %	10 M $
G. Loewenbaum 9.207 %	1,054,486	9.207 %	6 M $
Pinnacle Associates Ltd. 4.632 %	530,455	4.632 %	3 M $
Meitav DS Provident & Pension Ltd. 4.301 %	492,619	4.301 %	3 M $
Investment Management of Virginia LLC 4.051 %	463,899	4.051 %	2 M $
Roumell Asset Management LLC 3.778 %	432,639	3.778 %	2 M $
Hugh Evans 3.296 %	377,429	3.296 %	2 M $
St. Denis J. Villere & Co. LLC 3.204 %	366,967	3.204 %	2 M $
Brown Advisory LLC 1.044 %	119,536	1.044 %	639 518 $
Lilian S Loewenbaum 1.034 %	118,411	1.034 %	633 499 $

CollPlant Biotechnologies Ltd.

Weizmann Science Park 4 Oppenheimer Street

7670104, Rehovot

+972 73 232 5600

http://www.collplant.com

address CollPlant Biotechnologies Ltd.(CLGN)

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

5.89 USD

Average target price

11 USD

Spread / Average Target

+86.76%

Consensus

Estimates Revisions

Company calendar

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Bio Medical Devices

	1st Jan change	Capi.
COLLPLANT BIOTECHNOLOGIES LTD.	-6.57%	67.46M
MIMEDX GROUP, INC.	-28.62%	925M
NIBEC CO., LTD.	-19.49%	128M
KIM FOREST ENTERPRISE CO., LTD.	+5.69%	60.58M
BONUS BIOGROUP LTD.	+0.60%	51.45M

Bio Medical Devices